Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Prospective Randomized Study of Transarterial Chemoembolization Using Irinotecan Bead in Combination With Second Line Chemotherapy in the Treatment of Patients With Unresectable Metastatic Colorectal Cancer

NCT00816777 is registered in ClinicalTrials.gov with Generic Devices Consulting, Inc. as lead sponsor.

NCT NCT00816777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00816777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Prospective Randomized Study of Transarterial Chemoembolization Using Irinotecan Bead in Combination With Second Line Chemotherapy in the Treatment of Patients With Unresectable Metastatic Colorectal Cancer
Lead sponsor
Generic Devices Consulting, Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
December 31, 2008
Completion date
March 31, 2011
Enrollment
4 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable metastatic colo-rectal cancer